|
New Delhi, Sep 29: Serum Institute of India (SII) on Tuesday said it along with Gavi and the Bill and Melinda Gates Foundation will manufacture an additional up to 100 million COVID-19 vaccine doses for India and low- and middle-income countries (LMICs).
The latest collaboration between the partners brings the total number of vaccine doses to be covered to an aggregate of up to 200 million doses, SII said in a statement.
Health ministry launches web portal for updates on coronavirus vaccine development
In August, SII had entered into a new partnership with international vaccine alliance Gavi and…
